Exelixis Inc (EXEL.OQ)

EXEL.OQ on NASDAQ Stock Exchange Global Select Market

5.07USD
10:54am EDT
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.07
Open
$5.09
Day's High
$5.17
Day's Low
$5.01
Volume
64,966
Avg. Vol
411,847
52-wk High
$6.30
52-wk Low
$4.20

EXEL.OQ

Chart for EXEL.OQ

About

Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing its resources and development efforts on cabozantinib (XL184). It also has a portfolio of other compounds. Cabozantinib is the inhibitor of MET in clinical development and is... (more)

Overall

Beta: 1.93
Market Cap (Mil.): $930.04
Shares Outstanding (Mil.): 183.80
Dividend: --
Yield (%): --

Financials

  EXEL.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -0.97 -- --
ROI: -36.26 -2.58 18.76
ROE: -85.86 -2.66 19.59
Search Stocks

Competitors

  Price Change
AstraZeneca plc (AZN.L) 3,315.50p -19.50
Pfizer Inc. (PFE.N) $29.19 -0.04
ArQule, Inc. (ARQL.OQ) $2.69 +0.02
GlaxoSmithKline plc (GSK.L) 1,706.50p +22.50
Algeta ASA (ALGETA.OL) kr244.60 +3.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks